This is a routine governance filing with no immediate trading implications. Traders should monitor for any unexpected developments during the meeting or in the voting results, but no significant stock price movement is expected from this announcement alone.
MDWD drugs
MDWD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 31 $16.11entry
- T+1 · 8mo ago +0.56%α −0.19% · $16.20
- T+5 · 7mo ago +7.20%α +3.26% · $17.27
- T+20 · 7mo ago +1.52%α −7.90% · $16.36
- T+60 · 5mo ago −5.71%α −18.09% · $15.19
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
MediWound Ltd. (MDWD) has issued a 6-K filing to announce its 2026 Annual General Meeting of Shareholders, scheduled for May 6, 2026. The meeting will address the re-election of five board members, reappointment of the independent auditor Somekh Chaikin (KPMG), and approval of a $206,000 cash bonus for CEO Ofer Gonen for 2025 performance. This is a routine corporate governance filing with no immediate financial impact.
Key Facts
- Annual General Meeting scheduled for May 6, 2026
- Proposals include re-election of 5 directors: Nachum Shamir, Vickie R. Driver, David Fox, Shmuel Rubinstein, and Stephen T. Wills
- Reappointment of Somekh Chaikin (KPMG) as independent auditor for 2026
- Proposal to approve $206,000 cash bonus for CEO Ofer Gonen for 2025 performance
- Record date for voting is March 31, 2026
- Board unanimously recommends approval of all proposals
Financial Impact
Approximately $206,000 cash bonus for CEO if approved
Risk Factors
- Potential shareholder opposition to CEO bonus approval, though unlikely given board recommendation
- Low voter turnout could affect quorum requirements
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-001859 |
| Exhibit: exhibit_99-2.htm | 0001178913-26-001859 |
| Document: zk2634988.htm | 0001178913-26-001859 |
| Document: 0001178913-26-001859-index-headers.html | 0001178913-26-001859 |
| Document: 0001178913-26-001859-index.html | 0001178913-26-001859 |
| Document: 0001178913-26-001859.txt | 0001178913-26-001859 |
Track record
13 reports on MDWD
6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.80% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $12.90 Now $13.55 +5.04% settles Nov 20
- Nov 12, 20264d ago 6-K Bearish 6/10 No price data
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $12.97 Now $13.55 −4.47% settles Nov 19
- Nov 5, 202611d ago 6-K Bearish 6/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 3, 202613d ago 424B5 Bearish 5/10 Entry $14.20 to $13.82 Now $13.55 +4.58% ▲ +2.68% +1.76% vs SPY
- Sep 22, 20267w ago Press Release Bullish 4/10 Entry $13.95 to $13.80 Now $13.55 −2.87% ▼ −1.08% +0.11% vs SPY
- Jun 2, 202623w ago Insider Cluster Bullish 4/10 Entry $13.76 to $14.30 Now $13.55 −1.53% ▲ +3.92% +6.89% vs SPY
- May 27, 202624w ago Press Release Bearish 5/10 Entry $14.33 to $13.73 Now $13.55 +5.44% ▲ +4.19% +4.66% vs SPY
- May 7, 202627w ago Press Release Neutral 1/10 Entry $17.27 to $16.25 Now $13.55 −21.54% ▼ −5.91% −7.41% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers